ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,245Medicare Part D Prescriptions Filled, Including Refills

Rank: 998 out of 5176

$640K Total Retail Price of All Prescriptions

Rank: 734 out of 5176

399 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,603 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
PRAVASTATIN SODIUM 404 385 1 23
LOSARTAN POTASSIUM 334 309 2 14
LEVOTHYROXINE SODIUM 244 201 3 4
METOPROLOL TARTRATE 233 226 4 6
AMLODIPINE BESYLATE 222 208 5 2
METFORMIN HCL 218 206 6 7
METOPROLOL SUCCINATE 206 194 7 11
LOVASTATIN 195 187 8 46
LISINOPRIL 151 136 9 5
FUROSEMIDE 147 139 10 8
GLIPIZIDE 144 140 11 63
SIMVASTATIN 138 131 12 1
FLUTICASONE PROPIONATE 134 127 13 38
ATORVASTATIN CALCIUM 133 124 14 9
DIGOXIN 124 120 15 56
TORSEMIDE 115 115 16 184
FAMOTIDINE 114 95 17 58
WARFARIN SODIUM 113 106 18 13
AMIODARONE HCL 106 94 19 281
ATENOLOL 106 103 19 12
CARVEDILOL 103 94 21 24
DONEPEZIL HCL 90 83 22 28
ALLOPURINOL 89 82 23 41
VERAPAMIL ER 88 83 24 155
CLOPIDOGREL 84 77 25 26
OMEPRAZOLE 83 74 26 3
ENALAPRIL MALEATE 81 77 27 22
HYDROCHLOROTHIAZIDE 75 68 28 10
ZOLPIDEM TARTRATE 73 72 29 17
ALENDRONATE SODIUM 71 71 30 18
NAMENDA 70 65 31 47
CRESTOR 70 61 31 15
METFORMIN HCL ER 65 61 33 57
PLAVIX 61 54 34 29
JANUVIA 61 60 34 25
TRIAMTERENE-HCTZ 59 59 36 86
DIOVAN 59 58 36 19
SILVER SULFADIAZINE 58 58 38 207
NYSTATIN-TRIAMCINOLONE 58 57 38 142
SYNTHROID 57 57 40 33
PRADAXA 56 51 41 192
MULTAQ 55 55 42 414
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 43 35
SERTRALINE HCL 53 53 43 30
LORAZEPAM 52 52 45 446
RISPERIDONE 52 52 45 78
GEMFIBROZIL 51 37 47 139
TAMSULOSIN HCL 51 51 47 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.